Latest Breaking News On - Superkine immunotherapies - Page 4 : comparemela.com

Medicenna Therapeutics Corp : Medicenna Announces Trading on the OTCQB Under the Symbol MDNAF

Medicenna Therapeutics Corp : Medicenna Announces Trading on the OTCQB Under the Symbol MDNAF
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesChristina cameronSuperkine immunotherapiesStefan klotterToronto stock exchangeMedicenna therapeutics corpOrphan drugTargeted metalloprotease activated superkineAnnual reportLassen sie

Medicenna Announces Trading on the OTCQB Under the Symbol MDNAF

Medicenna Announces Trading on the OTCQB Under the Symbol MDNAF
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesChristina cameronSuperkine immunotherapiesMedicenna therapeutics corpToronto stock exchangeAnnounces tradingOrphan drugTargeted metalloprotease activated superkineAnnual report

Medicenna Announces Compelling Survival Benefit from Phase 2b Study of Bizaxofusp in Recurrent Glioblastoma at the 28th Annual Meeting of the Society for NeuroOncology

Medicenna Announces Compelling Survival Benefit from Phase 2b Study of Bizaxofusp in Recurrent Glioblastoma at the 28th Annual Meeting of the Society for NeuroOncology
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited statesSteven bremChristina cameronSuperkine immunotherapiesUniversity of pennsylvaniaMedicenna therapeutics corpMeeting of the society for neurooncologyCentre for precision surgerySingle administration of bizaxofuspAbramson cancer centerSociety for neuroPerelman school of medicineAnnounces compelling survival benefitRecurrent glioblastomaAnnual meeting

Medicenna Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Operational Highlights

Medicenna Therapeutics Reports Second Quarter Fiscal 2024 Financial Results and Operational Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaSuperkine immunotherapiesArash yavariHumphrey gardnerDevelopment advisory committeeMedicenna therapeutics corpSociety for neuroToronto stock exchangeConference in cancer researchFahar merchantChief executive officerYear follow upTargeted metalloprotease activated superkineCancer researchTumor immunology

Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp Survival Data in Recurrent Glioblastoma at the Society for Neuro-Oncology 2023 Annual Meeting

Medicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp Survival Data in Recurrent Glioblastoma at the Society for Neuro-Oncology 2023 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited statesSuperkine immunotherapiesSteven bremAbramson cancer centerSingle administration of bizaxofuspMedicenna therapeutics corpPerelman school of medicineUniversity of pennsylvaniaabstractSociety for neuroCentre for precision surgeryMedical directorPrecision surgeryPerelman schoolSurvival outcomesRecurrent glioblastoma